PureTech Health PLC
Company Profile
Business description
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
Contact
6 Tide Street
Suite 400
BostonMA02210
USAT: +1 617 482-2333
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
90
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,465.00 | 44.50 | 0.53% |
CAC 40 | 7,393.76 | 13.02 | 0.18% |
DAX 40 | 20,024.66 | 115.52 | 0.58% |
Dow JONES (US) | 42,417.35 | 126.87 | -0.30% |
FTSE 100 | 8,260.09 | 87.07 | 1.07% |
HKSE | 19,623.32 | 436.63 | -2.18% |
NASDAQ | 19,264.97 | 45.83 | -0.24% |
Nikkei 225 | 39,894.54 | 386.62 | -0.96% |
NZX 50 Index | 13,110.74 | 159.27 | -1.20% |
S&P 500 | 5,867.45 | 14.18 | -0.24% |
S&P/ASX 200 | 8,201.20 | 42.10 | 0.52% |
SSE Composite Index | 3,262.56 | 89.20 | -2.66% |